Alpha‐1 Adrenoceptor Blockade with Doxazosin in Hypertension: Effects on Blood Pressure and Lipoproteins

The Journal of Clinical Pharmacology

Volumn 29, Issue 2, 1989, Pages 123-127

  Ames, Richard P ^a   Kiyasu, John Y ^b  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b Serapine Laboratories ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; CHOLESTEROL; DOXAZOSIN; LIPOPROTEIN; PLACEBO; TRIACYLGLYCEROL;

ADULT; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; MALE; ORAL DRUG ADMINISTRATION; ORTHOSTATIC HYPOTENSION;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; BLOOD PRESSURE; CLINICAL TRIALS; DOUBLE-BLIND METHOD; DOXAZOSIN; FEMALE; HEART RATE; HUMAN; HYPERTENSION; LIPIDS; LIPOPROTEINS; MALE; PRAZOSIN; RANDOM ALLOCATION;

EID: 0024518052     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1989.tb03299.x     Document Type: Article

References (7)

1. Doxazosin, an alpha‐1 adreno‐ceptor antagonist: Pharmacokinetics and concentration‐effect relationships in man
2. Plasma high density lipoprotein cholesterol concentrations determined after removal of other lipoproteins by heparin‐manganese chloride precipitation or by ultracentrifugation
3. New micromethod for measuring cholesterol in plasma lipoprotein fractions
4. Effects of prazosin and clonidine on sympathetic and baroreflex function in patients with essential hypertension
5. Profile of trimazosin: An effective and safe antihypertensive agent
6. Comparison of the safety and efficacy of once‐daily terazosin versus twice daily prazosin for the treatment of mild to moderate hypertension
7. Multicenter 12‐week double‐blind comparison of doxazosin, prazosin and placebo in patients with mild to moderate essential hypertension